Compounds > goralatide
Page last updated: 2024-08-24

goralatide and Anemia

goralatide has been researched along with Anemia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujioka, K; Fujioka, T; Itoh, H; Katagiri, F; Mimata, H; Sato, F; Sato, Y; Suzuki, Y1
Adams, JW; Bernstein, KE; Capecchi, MR; Cole, JM; Corvol, P; Frenzel, K; Fuchs, S; Keshelava, G; Michaud, A; Xiao, HD; Zhao, H1
Lipsic, E; Schoemaker, RG; van de Wal, RM; van der Meer, P; van Gilst, WH; van Veldhuisen, DJ; Vellenga, E; Voors, AA; Westenbrink, BD1
Abu-Alfa, AK; Perazella, MA1

Other Studies

4 other study(ies) available for goralatide and Anemia

ArticleYear
Clinical Implications of Plasma N-acetyl-seryl-aspartyl-lysyl-proline Level in Stable Kidney Transplant Recipients.
    Clinical laboratory, 2016, Jul-01, Volume: 62, Issue:7

    Topics: Adolescent; Adult; Aged; Anemia; Angiotensin II; Biomarkers; Creatinine; Erythropoietin; Humans; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Oligopeptides; Postoperative Complications; Prolyl Oligopeptidases; Serine Endopeptidases; Young Adult

2016
Role of the N-terminal catalytic domain of angiotensin-converting enzyme investigated by targeted inactivation in mice.
    The Journal of biological chemistry, 2004, Apr-16, Volume: 279, Issue:16

    Topics: Anemia; Animals; Catalytic Domain; Mice; Oligopeptides; Peptidyl-Dipeptidase A; Point Mutation; Renin-Angiotensin System; Structure-Activity Relationship; Substrate Specificity

2004
Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure.
    Circulation, 2005, Sep-20, Volume: 112, Issue:12

    Topics: Aged; Anemia; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Echocardiography; Female; Glomerular Filtration Rate; Growth Inhibitors; Heart Failure; Hematopoiesis; Humans; Male; Myocardial Ischemia; Oligopeptides; Peptidyl-Dipeptidase A; Reference Values; Ventricular Function, Left

2005
Angiotensin-converting enzyme inhibitors and anemia in chronic kidney disease: a complex interaction.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 39, Issue:4

    Topics: Anemia; Angiotensin-Converting Enzyme Inhibitors; Erythropoiesis; Erythropoietin; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Oligopeptides

2002